Biopharmaceutical Firm, ViroPharma, Expands In Exton, Pa, Creating 151 New Jobs
09/14/2012
ViroPharma said it will nearly double its current available space by leasing an additional 71,000-square feet of office space at 730 Stockton Drive to accommodate planned growth. The expansion will enable the company hire at least 151 employees to its workforce of 188 within three years.
"For us it is about growth. ViroPharma has been in Exton for many years and we love our home here," said ViroPharma President and CEO Vincent J. Milano. "We're committed to this area for the long-term and look forward to creating opportunities in this community."
"ViroPharma is a true Pennsylvania success that continues to grow and create jobs in the region," said Gov. Tom Corbett. "What started as a small team of entrepreneurs in Exton has now evolved into an international biopharmaceutical company employing hundreds of Pennsylvanians.
As an incentive, the company received $583,000 in funding from the Department of Community and Economic Development, including a $130,000 Pennsylvania First grant and $453,000 in Job Creation Tax Credits.
"Chester County is fortunate to have companies like ViroPharma who continually innovate and reinvent themselves," said Chester County Economic Development Council President and CEO Gary Smith. "Their expansion is the latest evidence that the life science community in Chester County is alive and well." The amount of the company's capital investment was not immediately available.
Project Announcements
Canada-Based Dainty Foods Plans Batavia Township, Ohio, Manufacturing Operations
03/08/2026
AeroVironment Expands Albuquerque, New Mexico, Manufacturing Operations
03/08/2026
First Quality Home Care Products Plans Archbold, Ohio, Production Facility
03/08/2026
PPG Expands Delaware, Ohio, Manufacturing Operations
03/08/2026
J.M. Smucker Company Expands Topeka, Kansas, Operations
03/05/2026
Novartis Gene Therapies Plans Denton, Texas, Operations
03/04/2026
Most Read
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
Speed Built In—The Real Differentiator for 2026 Site Selection Projects
Q1 2026
-
What Companies Need from Modern Manufacturing Sites
Q1 2026
-
Preparing for the Next USMCA Shake-Up
Q4 2025
-
The New Industrial Revolution in Biotech
Q4 2025
-
Capitalizing on the OBBBA Before the 2026 Cliff
Q1 2026
-
The Skilled Trades Are Ready for a Digital Future
Q4 2025